biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by KayakerBCon Sep 07, 2016 2:08pm

309 Views

Post# 25214673

RE:RE:Trades Today

.i also understand that level 2 means nothing. ..but with a 50-100k day here as thin as it is...this would blow past 2$..

C'mon. Surely you know it doesn't work like that. As the price goes up, many thousands of shares will come into the market. It won't be as thin as it looks at the moment.

We've had several 100,000+ days in the past month and each time the stock moved up by 6¢ or less. Volume can come from enthusiastic sellers as well.

Your previous comment ("hardly 35000 shares for sale to hit 19$ a share") was in the same camp. On the road to $19, millions of shares would come into the market (>10 million IMO).

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!